LAKE FOREST, Ill. — Omron Healthcare Inc. has named Ranndy Kellogg as president and chief executive officer.

Kellogg, who previously was chief operating officer and took the reins at the new post on Thursday, succeeds former managing executive officer, president and CEO Seiji Takeda. Omron said Takeda will transition to the role of executive officer of global business strategy planning, sales and marketing for Europe and the Americas.

Ranndy Kellogg

“In his 12 years at Omron Healthcare, Ranndy Kellogg has been a respected leader for our company and in the field of blood pressure monitors. Mr. Kellogg’s new position will provide him with greater latitude to spearhead Omron’s continued growth and influence in the market,” Takeda stated. “On behalf of the board of directors, I would like to thank Ranndy for his stewardship and contributions to Omron Healthcare’s vision and growth for the past 11 years.”

Omron is a leading manufacturer and distributor of personal heart health and wellness products, including home blood pressure monitors and electrotherapy devices. Before coming to Omron, Kellogg served as vice president and director of marketing for Baxter Healthcare. Prior to that, he was group marketing manager at CR Bard.

“I am honored to have the opportunity to serve as CEO and president of Omron Healthcare and to lead our work forward to empower millions of people to take charge of their heart health through our most advanced, precise technology and tools on the market,” Kellogg commented.

“This year we are ramping up our mission to confront the ongoing epidemic of heart attacks and strokes. We will do that by building upon Omron’s heritage of accuracy with new products that provide deeper insights, encourage behavioral change and promote healthier lifestyle habits,” he added.

Omron noted that its executive team, led by Kellogg, gave a first look at the company’s “Project Zero” Wrist and Upper Arm Blood Pressure Monitors and the new Omron Connect App at the Consumer Electronic Show (CES) in Las Vegas earlier this year. The company said the clinically tested, highly accurate heart health tools, designed to improve heart health for millions of hypertensive individuals, will be available this year and are part of a major heart health initiative that the Omron is rolling out in 2016.